Six new option listings and four option delistings on March 19th

New option listings for March 19th include Colombier Acquisition Corp II (CLBR), Danimer Scientific, Inc. (DNMRQ), Kalaris Therapeutic Inc. (KLRS), Niagen Bioscience Inc (NAGE), Sunrise Realty Trust Inc (SUNS), and Whitehawk Therapeutics Inc (WHWK). Option delistings effective March 19th include Danimer Scientific Inc (DNMR), ChromaDex (CDXC), AlloVir (ALVR), and Aadi Bioscience (AADI).